ELUXADOLINE DEMONSTRATES EFFICACY FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH DIARRHOEA (IBS-D) AMONG MULTIPLE CLINICALLY RELEVANT PATIENT SUBGROUPS

被引：2
|
作者：
Lacy, B. [1 ]
Chey, W. [2 ]
Lembo, A. [3 ]
Dove, L. S. [4 ]
Covington, P. S. [4 ]
机构：
[1] Geisel Sch Med, Hanover, NH USA
[2] Univ Michigan, Ann Arbor, MI USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Furiex Pharmaceut Inc, Parsippany, NJ USA
来源：
GUT | 2016年 / 65卷
关键词：
D O I：
10.1136/gutjnl-2016-312388.69
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-070
引用
收藏
页码：A42 / A43
页数：2
相关论文
共 50 条
  • [41] Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
    Kemppinen, Anu
    Howell, Carol
    Allgar, Victoria
    Dodd, Matthew
    Gregson, John
    Knowles, Charles
    McLaughlin, John
    Pandya, Preeti
    Whorwell, Peter
    Markaryan, Elena
    Yiannakou, Yan
    [J]. TRIALS, 2020, 21 (01)
  • [42] Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
    Anu Kemppinen
    Carol Howell
    Victoria Allgar
    Matthew Dodd
    John Gregson
    Charles Knowles
    John McLaughlin
    Preeti Pandya
    Peter Whorwell
    Elena Markaryan
    Yan Yiannakou
    [J]. Trials, 21
  • [43] Plasma 5-hydroxytryptamine concentration varies with gender and menstrual status in irritable bowel syndrome patients with diarrhoea (IBS-D) but not healthy volunteers
    Houghton, Lesley A.
    Perry, Heather
    Morris, Julie
    Whorwell, Peter J.
    Keevil, Brian
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A681 - A681
  • [44] Editorial: Tong-Xie-Yao-Fang (TXYF) for irritable bowel syndrome with diarrhoea (IBS-D)-ancient medicine meets modern study
    Vitta, S.
    Sayuk, G. S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (04) : 485 - 486
  • [45] Getting the BS out of Irritable Bowel Syndrome with Diarrhea (IBS-D): Let’s Make a Diagnosis
    Frissora C.L.
    Schiller L.R.
    [J]. Current Gastroenterology Reports, 2024, 26 (1) : 20 - 29
  • [46] Concordance Among Outcome Variables Assessing the Response to Treatment With Ibodutant in Irritable Bowel Syndrome With Diarrhea (IBS-D; the IRIS-2 Study)
    Tack, Jan F.
    Capriati, Angela
    Schumacher, Kai
    Ligas, Franca
    Ott, Kerstin
    Tonini, Giulia
    Scartoni, Simona
    Otranto, Isabella
    Nuti, Alessandra
    Maggi, Carlo Alberto
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S194 - S194
  • [47] Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Rezaie, Ali
    Heimanson, Zeev
    Israel, Robert J.
    McCallum, Richard
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S269 - S269
  • [48] POTENTIAL FOR COST SAVINGS ASSOCIATED WITH A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): ITALIAN PERSPECTIVE
    Gabbani, T.
    Violanti, C.
    Deiana, S.
    Pimentel, M.
    Purdy, C.
    Magar, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A349 - A350
  • [49] TRANSLATABILITY ASSESSMENT AND LINGUISTIC VALIDATION OF THE PATIENT-REPORTED OUTCOME INSTRUMENT FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D PRO)
    Popielnicki, A.
    Arbuckle, R.
    Banderas, B.
    Delgado-Herrera, L.
    Gagainis, I
    Lasch, K.
    Nishida, A.
    Zeiher, B.
    Zentner, S.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A630 - A630
  • [50] Efficacy of pinaverium bromide in the treatment of Irritable Bowel Syndrome (IBS): A meta-analysis
    Bor, Serhat
    Lehert, Philippe
    Chalbaud, Adriana
    Tack, Jan
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 346 - 346
12345